Extractionless method for the determination of urinary caffeine metabolites using high-performance liquid chromatography coupled with tandem mass spectrometry.

作者: Heiko Schneider , Lan Ma , Hansruedi Glatt

DOI: 10.1016/S1570-0232(03)00065-5

关键词:

摘要: Caffeine is metabolised in humans primarily by cytochromes P450 1A2 and 2A6, xanthine dehydrogenase/oxidase, N-acetyltransferase 2. The activities of these enzymes show a large variation due to genetic polymorphisms and/or induction xenobiotics. Ratios different caffeine metabolites urine or other body fluids are frequently used characterise the individual/actual activity enzymes. common analytical method involves extensive sample preparation, followed HPLC–UV. presence numerous UV-absorbing chemicals affects sensitivity selectivity this method. We have developed an HPLC–electrospray-MS–MS for determination 11 two internal standards after simple, extractionless preparation. Blank urine, obtained 5 days on methylxanthine-free diet, contained small amounts some metabolites, but no components producing any confounding signals. Eleven were recovered at 90 110% addition blank (0.1 2.5 μM final involving 20-fold dilution urine) 0.1–2.5 concentration range. Other 5-acetylamino-6-amino-3-methyluracil (AAMU) 5-acetylamino-6-formylamino-3-methyluracil (AFMU), detected with similar recovery precision, required higher concentrations (3 30 μM). AFMU was completely converted into AAMU short alkalisation urine. explored six healthy individuals consuming coffee (4 mg per kg mass). These experiments demonstrated simplicity, high under conditions phenotyping.

参考文章(32)
G Paintaud, H Lelouët, M P Brientini, Y C Bechtel, M David-Laroche, J P Miguet, P R Bechtel, Caffeine metabolism differences in acute hepatitis of viral and drug origin. Therapie. ,vol. 55, pp. 619- 627 ,(2000)
J M Carney, H D Christensen, L A Reinke, M Nakamura, L Logan, In vivo and in vitro 1-methylxanthine metabolism in the rat. Evidence that the dehydrogenase form of xanthine oxidase predominates in intact perfused liver. Drug Metabolism and Disposition. ,vol. 15, pp. 295- 299 ,(1987)
J F Tjia, J Colbert, D J Back, Theophylline metabolism in human liver microsomes: inhibition studies. Journal of Pharmacology and Experimental Therapeutics. ,vol. 276, pp. 912- 917 ,(1996)
Bing-Kou Tang, D Kadar, Li Qian, Jessie Iriah, James Yip, Werner Kalow, Caffeine as a metabolic probe: Validation of its use for acetylator phenotyping Clinical Pharmacology and Therapeutics. ,vol. 49, pp. 648- 657 ,(1991) , 10.1038/CLPT.1991.82
Cyrille Krul, Geja Hageman, Analysis of urinary caffeine metabolites to assess biotransformation enzyme activities by reversed-phase high-performance liquid chromatography Journal of Chromatography B: Biomedical Sciences and Applications. ,vol. 709, pp. 27- 34 ,(1998) , 10.1016/S0378-4347(98)00016-4
A Rostami-Hodjegan, S Nurminen, P R Jackson, G T Tucker, Caffeine urinary metabolite ratios as markers of enzyme activity: a theoretical assessment. Pharmacogenetics. ,vol. 6, pp. 121- 149 ,(1996) , 10.1097/00008571-199604000-00001
Hideko Kanazawa, Ryoko Atsumi, Yoshikazu Matsushima, Junko Kizu, Determination of theophylline and its metabolites in biological samples by liquid chromatography–mass spectrometry Journal of Chromatography A. ,vol. 870, pp. 87- 96 ,(2000) , 10.1016/S0021-9673(99)00891-2
M. A. Butler, N. P. Lang, J. F. Young, N. E. Caporaso, P. Vineis, R. B. Hayes, C. H. Teitel, J. P. Massengill, M. F. Lawsen, F. F. Kadlubar, Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics. ,vol. 2, pp. 116- 127 ,(1992) , 10.1097/00008571-199206000-00003